For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
EOIs open for regional Consumer Councils

Health New Zealand is setting up four Regional Consumer Councils to strengthen the voice of consumers, whānau and communities in design, delivery and monitoring of health services for all New Zealanders.
Director Consumer Engagement and Whānau Voice, Hector Matthews, says the move from local consumer councils to regional councils will ensure consumers are heard at national, regional and local level. Consumer learnings and insights will be applied more consistently across our healthcare networks.
“The Code of Expectations for consumer engagement, under Pae Ora legislation, expects Health NZ to ensure the consumer voice is at the heart of our mahi. “
“There is already a wide array of local mechanisms through which consumers are advising Health NZ around the country, including Iwi-Māori Partnership boards, governance and steering groups and advice on specific projects. This engagement will continue and inform the work of the Regional Councils.’’
Expressions of interest opened on 13 May for the Councils, expected to be in place by 1 July. EOIs are required by close of business 3 June 2024 and successful applicants will be announced by 21 July.
More information including EOI forms can be found here.